ImmunoPrecise Antibodies Ltd. (HYFT)

ImmunoPrecise Antibodies Ltd. (HYFT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $60.8M; returns 1 day -3.3%, 1 week -11.5%, 1 year -24.7%.

ImmunoPrecise Antibodies Ltd., which rebranded as MindWalk Holdings Corp. (HYFT) in September 2025, is a biotechnology company that operates at the intersection of traditional antibody discovery and advanced artificial intelligence (AI).

Groups HYFT belongs to

• Biotechnology
• Artificial Intelligence
• Drug Discovery
• Life Sciences Tools & Services
• Antibody Therapeutics
• AI Software
• Biopharmaceutical
• Contract Development and Manufacturing Organizations (CDMO)
• Healthcare Technology
• AI in Healthcare

HYFT financial model: income statement, cash flow and balance sheet